These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11375769)

  • 1. 3-D pharmacophores in drug discovery.
    Mason JS; Good AC; Martin EJ
    Curr Pharm Des; 2001 May; 7(7):567-97. PubMed ID: 11375769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity.
    Mason JS; Beno BR
    J Mol Graph Model; 2000; 18(4-5):438-51, 538. PubMed ID: 11143561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Library design and virtual screening using multiple 4-point pharmacophore fingerprints.
    Mason JS; Cheney DL
    Pac Symp Biocomput; 2000; ():576-87. PubMed ID: 10902205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore discovery--lessons learned.
    van Drie JH
    Curr Pharm Des; 2003; 9(20):1649-64. PubMed ID: 12871063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
    J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oriented substituent pharmacophore PRopErtY space (OSPPREYS): a substituent-based calculation that describes combinatorial library products better than the corresponding product-based calculation.
    Martin EJ; Hoeffel TJ
    J Mol Graph Model; 2000; 18(4-5):383-403. PubMed ID: 11143557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening.
    Good AC; Cho SJ; Mason JS
    J Comput Aided Mol Des; 2004; 18(7-9):523-7. PubMed ID: 15729851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening.
    Xue L; Bajorath J
    Comb Chem High Throughput Screen; 2000 Oct; 3(5):363-72. PubMed ID: 11032954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Molecular Descriptors on Computational Models.
    Grisoni F; Consonni V; Todeschini R
    Methods Mol Biol; 2018; 1825():171-209. PubMed ID: 30334206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modeling in drug discovery and development: an overview.
    Khedkar SA; Malde AK; Coutinho EC; Srivastava S
    Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-receptor 3-D similarity studies using multiple 4-point pharmacophores.
    Mason JS; Cheney DL
    Pac Symp Biocomput; 1999; ():456-67. PubMed ID: 10380219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
    Bonachéra F; Parent B; Barbosa F; Froloff N; Horvath D
    J Chem Inf Model; 2006; 46(6):2457-77. PubMed ID: 17125187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
    Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
    Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History and evolution of the pharmacophore concept in computer-aided drug design.
    Güner OF
    Curr Top Med Chem; 2002 Dec; 2(12):1321-32. PubMed ID: 12470283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction of pharmacophore information from high-throughput screens.
    Hopfinger AJ; Duca JS
    Curr Opin Biotechnol; 2000 Feb; 11(1):97-103. PubMed ID: 10679338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design of combinatorial libraries using properties and 3D pharmacophore fingerprints.
    Beno BR; Mason JS
    Drug Discov Today; 2001 Mar; 6(5):251-258. PubMed ID: 11182598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.